, Tracking Stock Market Picks
Enter Symbol:
Relx N.V. (RENX) [hlAlert]

down 36.69 %

Reed Elsevier Nv (ENL) rated Underperform by BofA/Merrill

Posted on: Thursday,  Dec 13, 2012  8:25 AM ET by BofA/Merrill

BofA/Merrill rated Underperform Relx N.V. (NYSE: RENX) on 12/13/2012, when the stock price was $9.47. Since
then, Relx N.V. has gained 57.96% as of 12/31/2016's recent price of $14.96.
If you would have followed this BofA/Merrill's recommendation on RENX, you would have lost 36.69% of your investment in 1479 days.

Reed Elsevier NV is a publisher and information provider. The Company?s activities include science and medical, legal and business publishing and the organisation of trade exhibitions. Its principal operations are in North America and Europe. The Company?s businesses provide products and services that are organized in four business divisions: Elsevier serves the science and medical sector; LexisNexis, the legal and other professional sectors, Reed Exhibitions, the exhibitions and conferences sector; and Reed Business Information, the trade magazines and information business sector. On September 19, 2008, the Company acquired ChoicePoint, Inc.

Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/13/2012 8:25 AM Sell
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy